Optimizing the use of alkylators in neuro-oncology

Article English OPEN
Perry, J R; Wick, W; Weller, M;
  • Publisher: American Society of Clinical Oncology
  • Related identifiers: doi: 10.5167/uzh-57536
  • Subject: Clinic for Neurology | 610 Medicine & health
    mesheuropmc: neoplasms

For more than three decades, alkylating agents have been the most widely used class of chemotherapeutic agents for the treatment of glial brain tumors. Today, concomitant and adjuvant temozolomide is the standard of care for newly diagnosed glioblastoma. Temozolomide al... View more
Share - Bookmark